Organization: GeneChem LP

Cytochroma Inc raises additional $21 million in VC

Privately held Cytochroma Inc, Markham ON, has received $21 million in venture capital financing to expand the development of potential products for vitamin D deficiency and other diseases related to chronic kidney disease. The latest funding brings the total raised since 2001 to $58 million and follows last year’s acquisition of Madison WI-based Proventiv Therapeutics…